Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterparts
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01AI084004, R01AI097177)
- U.S. Department of Energy Office of Basic Energy Sciences (DE-AC02-76SF00515)
- National Institutes of Health (P41GM103393)
This publication has 43 references indexed in Scilit:
- The Phyre2 web portal for protein modeling, prediction and analysisNature Protocols, 2015
- A human tRNA synthetase is a potent PARP1-activating effector target for resveratrolNature, 2014
- 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: Synthesis, molecular docking and antibacterial evaluationBioorganic & Medicinal Chemistry, 2013
- The Double-Length Tyrosyl-tRNA Synthetase from the Eukaryote Leishmania major Forms an Intrinsically Asymmetric Pseudo-DimerJournal of Molecular Biology, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing SiteScience, 2007
- Synthetic analogues of SB-219383. Novel C-glycosyl peptides as inhibitors of tyrosyl tRNA synthetaseBioorganic & Medicinal Chemistry Letters, 2001
- Aminoacyl tRNA synthetases as targets for new anti‐infectivesThe FASEB Journal, 1998